- Home
- ROIV vs LH Comparison
ROIV vs LH Comparison
Compare ROIV & LH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ROIV | LH |
|---|---|---|
| Founded | 2014 | 1971 |
| Country | United Kingdom | United States |
| Employees | 721 | 70000 |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.7B | 25.9B |
| IPO Year | 2021 | 2005 |
Fundamental Metrics
Financial Performance| Metric | ROIV | LH |
|---|---|---|
| Price | $38.99 | $320.99 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 9 |
| Target Price | $28.94 | ★ $311.33 |
| AVG Volume (30 Days) | ★ 8.5M | 643.1K |
| Earning Date | 05-28-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 1.12% |
| EPS Growth | N/A | ★ 18.33 |
| EPS | N/A | ★ 6.99 |
| Revenue | $8,260,000.00 | ★ $13,951,700,000.00 |
| Revenue This Year | N/A | $8.26 |
| Revenue Next Year | $744.61 | $4.81 |
| P/E Ratio | ★ N/A | $45.93 |
| Revenue Growth | N/A | ★ 7.25 |
| 52 Week Low | $14.50 | $244.52 |
| 52 Week High | $42.50 | $341.80 |
Technical Indicators
Market Signals| Indicator | ROIV | LH |
|---|---|---|
| Relative Strength Index (RSI) | 55.79 | 51.36 |
| Support Level | $33.15 | $250.82 |
| Resistance Level | $42.50 | $341.80 |
| Average True Range (ATR) | 1.45 | 7.97 |
| MACD | 0.05 | -1.37 |
| Stochastic Oscillator | 60.80 | 54.36 |
Price Performance
Historical ComparisonAbout ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About LH Laboratory Corporation of America Holdings
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from uncomplicated routine blood and urine screens to complex oncology and genomic testing.